Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.

Схожие документы

• A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
  по: Lissoni, P., et al.
  Опубликовано: (1994)
• Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
  по: Lissoni, P., et al.
  Опубликовано: (1991)
• Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
  по: Lissoni, P., et al.
  Опубликовано: (1992)
• Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
  по: Lissoni, P., et al.
  Опубликовано: (1995)
• A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
  по: Lissoni, P., et al.
  Опубликовано: (1996)